À propos
Dr Iqtedar A. Muazzam is a Consultant Medical Oncologist at Hull University Teaching Hospitals NHS Trust, a role he has held since 2015. He specialises in the treatment of cancer using systemic therapies such as chemotherapy, immunotherapy, anticancer antibodies, targeted small molecules, and hormonal (endocrine) treatments. His clinical expertise covers breast, ovarian, and prostate cancers, and he has a particular interest in the management and research of urologic cancers.
In addition to his role at Hull, Dr Muazzam also serves as a visiting medical oncologist at the North Lincolnshire and Goole Foundation Trust and the United Lincolnshire Hospitals NHS Trust, where he manages patients with lung and skin cancers, including melanoma.
Dr Muazzam is also lead for Teenage and Young Adult Cancers at Hull University Teaching Hospitals NHS Trust.
Dr Muazzam is actively involved in national clinical research as a study investigator and maintains up-to-date knowledge of emerging anticancer strategies to provide the best outcomes for his patients. He had served as the Lead for Acute Oncology Services and currently chairs for Morbidity and Mortality Reviews within the Oncology Department at Hull University Teaching Hospitals NHS Trust. He also leads multiple clinical audits and quality improvement initiatives aimed at enhancing oncology care.
Alongside his clinical responsibilities, Dr Muazzam is an Honorary Lecturer at the Hull York Medical School. He is the current chair of Medical Oncology Examination Board for the Federation of Royal Colleges UK. He is dedicated to the teaching and training of medical students and postgraduate trainees in Internal Medicine and Oncology.
In addition to his role at Hull, Dr Muazzam also serves as a visiting medical oncologist at the North Lincolnshire and Goole Foundation Trust and the United Lincolnshire Hospitals NHS Trust, where he manages patients with lung and skin cancers, including melanoma.
Dr Muazzam is also lead for Teenage and Young Adult Cancers at Hull University Teaching Hospitals NHS Trust.
Dr Muazzam is actively involved in national clinical research as a study investigator and maintains up-to-date knowledge of emerging anticancer strategies to provide the best outcomes for his patients. He had served as the Lead for Acute Oncology Services and currently chairs for Morbidity and Mortality Reviews within the Oncology Department at Hull University Teaching Hospitals NHS Trust. He also leads multiple clinical audits and quality improvement initiatives aimed at enhancing oncology care.
Alongside his clinical responsibilities, Dr Muazzam is an Honorary Lecturer at the Hull York Medical School. He is the current chair of Medical Oncology Examination Board for the Federation of Royal Colleges UK. He is dedicated to the teaching and training of medical students and postgraduate trainees in Internal Medicine and Oncology.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Iqtedar A Muazzam
Formation et études
-
2005–2011 MD · Medicine and Surgery
-
2011–2015 Residency · Oncologie
Carrière et postes
-
2015-09–2016-08 Junior consultant
Licences et assurance
Licences médicales
GB — Organización Médica Colegial de España (OMC)
Certifications du conseil
European Board of Oncologie
Assurance responsabilité professionnelle :
HDI Global · 3,000,000 EUR couverture · No claims on file
Procédures réalisées
| Procédure | Code | Total à vie |
|---|---|---|
| GP consultation | 99213 | 2,083 |
| Annual physical exam | 99395 | 2,709 |
| Vaccination administration | 90471 | 2,333 |
| Minor procedure (skin) | 17110 | 690 |
Services et tarifs
| Service | Durée | Modalité | Prix |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 540.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 810.00 EUR |
Cabinet, équipe & en pratique
Vidéos
Recherche et publications
indice h : 7 · i10 : 7
-
Long-term follow-up of Oncologie across GB
DOI: 10.5105/euroclin.2026.0 · PMID: 32011033 · cité par 123
-
Validation of clinical scoring in Oncologie
DOI: 10.6624/euroclin.2025.1 · PMID: 37678239 · cité par 129
-
Long-term follow-up of Oncologie across GB
DOI: 10.3118/euroclin.2024.2 · PMID: 36595711 · cité par 23
-
Validation of clinical scoring in Oncologie
DOI: 10.8201/euroclin.2023.3 · PMID: 30642076 · cité par 189
Conférences invitées
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · Hull · 2023 · oral abstract
Récompenses et adhésions
Récompenses
- 🏆 Top-rated Oncologie — Hull · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Adhésions à des sociétés
- WONCA Europe — Family Doctors — Member · Depuis 2016
- national college of family doctors — Member · Depuis 2016
- European Union of Medical Specialists (UEMS) — Member · Depuis 2016
Articles de ce médecin
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Pour les patients internationaux
- Coordinateur
- Patient liaison · iqtedar.ahmed.muazzam@euroclinics.example
- Assurances internationales acceptées
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Emplacement
1 baliseAvis des patients
24 avis vérifiés4.90
★★★★⯨
24 avis
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.7
- Staff Friendliness
- 4.9
- Ease Of Appointment
- 4.8
- Value For Money
- 4.8
- Would Recommend Pct
- 97.0
Partagez votre expérience — aidez d'autres patients à trouver le bon médecin. Rédiger un avis →
Avis récents
-
★★★★★ ✓ Vérifié Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Vérifié Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Vérifié Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.